HTSI editor’s letter: fat-loss diaries, a fabulous home and the queen of high-street fashion

In recent weeks, the drug has become the subject of public (and private) discourse as we debate the ethics and efficacy of the weight-loss aid. [...]it’s controversial – what discussion of weight loss is ever not? I know several people who have been prescribed Ozempic (a semaglutide brand name), and...

Full description

Saved in:
Bibliographic Details
Published inFT.com
Main Author Ellison, Jo
Format Newspaper Article
LanguageEnglish
Published London The Financial Times Limited 25.03.2023
Subjects
Armenian Americans
Eating behavior
Online AccessGet full text

Cover

More Information
Summary:In recent weeks, the drug has become the subject of public (and private) discourse as we debate the ethics and efficacy of the weight-loss aid. [...]it’s controversial – what discussion of weight loss is ever not? I know several people who have been prescribed Ozempic (a semaglutide brand name), and I’ve been a fascinated onlooker as the drug has taken hold. [...]I am honoured that Marta Ortega Pérez agreed to grant an exclusive interview to this magazine.